StonvexLoading…
StonvexStonvexStonvexCore line items from NJR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.08B | $440.90M | $1.35B | $1.16B |
Operating Income | $480.24M | $179.21M | $508.87M | $468.46M |
Net Income | $341.40M | $122.49M | $335.63M | $320.56M |
EPS (Diluted) | $3.37 | $1.21 | $3.33 | $3.18 |
Total Assets | $7.94B | $7.91B | $7.58B | $7.27B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $125.28M | $2.43M | $591.00K | $931.00K |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 100.86M | 100.75M | 100.48M | 100.38M |